Supplementation of the diet with silicic acid to reduce body burden of aluminum: A miracle cure or useless treatment for Alzheimer's disease?

Journal of Alzheimer's Disease

Volumn 10, Issue 1, 2006, Pages 25-27

  Savory, John ^a,d   Herman, Mary M ^b   Ghribi, Othman ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; DRINKING WATER; SILICIC ACID;

ALUMINUM OVERLOAD; ALZHEIMER DISEASE; BODY BURDEN; DIET SUPPLEMENTATION; HUMAN; NERVE DEGENERATION; NOTE; PARENTERAL NUTRITION; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; URINARY EXCRETION;

ALUMINUM; ALZHEIMER DISEASE; DIETARY SUPPLEMENTS; HUMANS; SILICIC ACID;

EID: 33748752025     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-10104     Document Type: Note

References (13)

1. R.L. Commissaris, J.J. Cordon, S. Sprague, J. Keiser, G.H. Mayor and R.H. Rech, Behavioral changes in rats after chronic aluminum and parathyroid hormone administration, Neurobehav. Toxicol. Teratol. 4 (1982), 403-410.
2. D.R. Crapper McLachlan, A.J. Dalton, T.P. Kruck, M.Y. Bell, W.L. Smith, W. Kalow and D.F. Andrews, Intramuscular desferrioxamine in patients with Alzheimer's disease, Lancet 337 (1991), 1304-1308.
3. D.R. Crapper, S.S. Krishnan and A.J. Dalton, Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration, Trans. Am. Neurol. Assoc. 98 (1973), 17-20.
4. C. Exley, O. Korchazhkina, D. Job, S. Strekopytov, A. Polwart and P. Crome, Non-invasive therapy to reduce the body burden of aluminium in Alzheimer's disease, J. Alzheimers Dis. (2006), in press.
5. R.T. Erasmus, J. Kusnir, W.C. Stevenson, P. Lobo, M.M. Herman, M.R. Wills and J. Savory, Hyperaluminemia associated with liver transplantation and acute renal failure, Clin. Transplant. 9 (1995), 307-311.
6. R.M. Garruto, R. Fukatsu, R. Yanagihara, D.C. Gajdusek, G. Hook and C.E. Fiori, Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam, Proc. Natl. Acad. Sci. USA 81 (1984), 1875-1879.
7. G.L. Klein, A.M. Leichtner and M.B. Heyman, Aluminum in large and small volume parenterals used in total parenteral nutrition: response to the Food and Drug Administration notice of proposed rule by the North American Society for Pediatric Gastroenterology and Nutrition, J. Pediatr. Gastroenterol Nutr. 27 (1998), 457-460.
8. C.N. Martyn, D.J. Barker, C. Osmond, E.C. Harris, J.A. Edwardson and R.F. Lacey, Geographical relation between Alzheimer's disease and aluminum in drinking water, Lancet 1 (1989), 59-62.
9. J. Savory, O. Ghribi, M.S. Forbes and M.M. Herman, The rabbit model system for studies of aluminum-induced neurofibrillary degeneration: relevance to human neurodegenerative disorders, in: Aluminum and Alzheimer's Disease, C. Exley, ed., Elsevier, 2001, pp. 203-219.
10. J. Savory, O. Ghribi and M.M. Herman, Is amyloid beta-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions?, Neurobiol. Aging 23 (2002), 1089-1092.
11. J. Savory, C. Exley, W.F. Forbes, Y. Huang, J.G. Joshi, T. Kruck, D.R. McLachlan and I. Wakayama, Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?, J. Toxicol. Environ. Health 48 (1996), 615-635.
12. D.M. White, W.T. Longstreth, Jr., L. Rosenstock, K.H. Claypoole, C.A. Brodkin and B.D. Townes, Neurologic syndrome in 25 workers from an aluminum smelting plant, Arch. Intern. Med. 152 (1992), 1443-1448.
13. M.R. Wills and J. Savory, Water content of aluminum, dialysis dementia, and osteomalacia, Environ. Health Perspect. 63 (1985), 141-147.